APA (7th ed.) Citation

Filippatos, G., Anker, S. D., Butler, J., Farmakis, D., Ferreira, J. P., Gollop, N. D., . . . Packer, M. (2022). Effects of empagliflozin on cardiovascular and renal outcomes in heart failure with reduced ejection fraction according to age: A secondary analysis of EMPEROR-Reduced. European journal of heart failure, 24(12), . https://doi.org/10.1002/ejhf.2707

Chicago Style (17th ed.) Citation

Filippatos, Gerasimos, et al. "Effects of Empagliflozin on Cardiovascular and Renal Outcomes in Heart Failure with Reduced Ejection Fraction According to Age: A Secondary Analysis of EMPEROR-Reduced." European Journal of Heart Failure 24, no. 12 (2022). https://doi.org/10.1002/ejhf.2707.

MLA (9th ed.) Citation

Filippatos, Gerasimos, et al. "Effects of Empagliflozin on Cardiovascular and Renal Outcomes in Heart Failure with Reduced Ejection Fraction According to Age: A Secondary Analysis of EMPEROR-Reduced." European Journal of Heart Failure, vol. 24, no. 12, 2022, https://doi.org/10.1002/ejhf.2707.